Search research articles
Contact Us
Filters
Showing results (101-110 of 122) with videos related to
Page
of 13
Sort By:
Journal for Immunotherapy of Cancer
|
August 30, 2020
Brain metastasis PD-L1 and CD8 expression is dependent on primary tumor type and its PD-L1 and CD8 status
Florian Camy, Georgia Karpathiou, Jean Marc Dumollard, et al.
Annales De Pathologie
|
October 13, 2019
[Guidelines for the macroscopic management of surgically resected lung carcinoma]
Audrey Mansuet-Lupo, Marc Filaire, Philippe Chaffanjon, et al.
Virchows Archiv : an International Journal of Pathology
|
January 21, 2021
Morphologic and molecular classification of lung neuroendocrine neoplasms
Jasna Metovic, Marco Barella, Fabrizio Bianchi, et al.
The Journal of Pathology
|
February 25, 2026
Pathological classification of Fuchs endothelial corneal dystrophy into several types and their relationships with CTG18.1 expansion repeats
Hanielle Vaitinadapoulé, Daria Onitiu, Corantin Maurin, et al.
Frontiers in Immunology
|
December 6, 2021
Therapeutic Potential of Anti-Interferon α Vaccination on SjS-Related Features in the MRL/lpr Autoimmune Mouse Model
Martin Killian, Fabien Colaone, Philippe Haumont, et al.
Plos One
|
July 23, 2020
Ex vivo model of herpes simplex virus type I dendritic and geographic keratitis using a corneal active storage machine
Emilie Courrier, Corantin Maurin, Victor Lambert, et al.
Acta Neuropathologica Communications
|
November 21, 2013
ALDH1 is an immunohistochemical diagnostic marker for solitary fibrous tumours and haemangiopericytomas of the meninges emerging from gene profiling study
Corinne Bouvier, François Bertucci, Philippe Métellus, et al.
Translational Lung Cancer Research
|
August 9, 2024
Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients with rare <i>KRAS</i> mutations: a real-world retrospective study
Haohua Jiang, Yujing Li, Yanan Wang, et al.
Translational Lung Cancer Research
|
January 13, 2023
Adjuvant chemotherapy for completely resected IIA-IIIA non-small cell lung cancer: compliance to guidelines, safety and efficacy in real-life practice
Anne-Laure Désage, Claire Tissot, Sophie Bayle-Bleuez, et al.
Chemotherapy
|
April 9, 2016
Clinical Impact of Bevacizumab in Patients with Relapsed Glioblastoma: Focus on a Real-Life Monocentric SurVey (SV1 Study)
Romain Rivoirard, Cyrus Chargari, Jean-Baptiste Guy, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 122) with videos related to
Sort By:
Page
of 13
Journal for Immunotherapy of Cancer
|
August 30, 2020
Brain metastasis PD-L1 and CD8 expression is dependent on primary tumor type and its PD-L1 and CD8 status
Florian Camy, Georgia Karpathiou, Jean Marc Dumollard, et al.
Annales De Pathologie
|
October 13, 2019
[Guidelines for the macroscopic management of surgically resected lung carcinoma]
Audrey Mansuet-Lupo, Marc Filaire, Philippe Chaffanjon, et al.
Virchows Archiv : an International Journal of Pathology
|
January 21, 2021
Morphologic and molecular classification of lung neuroendocrine neoplasms
Jasna Metovic, Marco Barella, Fabrizio Bianchi, et al.
The Journal of Pathology
|
February 25, 2026
Pathological classification of Fuchs endothelial corneal dystrophy into several types and their relationships with CTG18.1 expansion repeats
Hanielle Vaitinadapoulé, Daria Onitiu, Corantin Maurin, et al.
Frontiers in Immunology
|
December 6, 2021
Therapeutic Potential of Anti-Interferon α Vaccination on SjS-Related Features in the MRL/lpr Autoimmune Mouse Model
Martin Killian, Fabien Colaone, Philippe Haumont, et al.
Plos One
|
July 23, 2020
Ex vivo model of herpes simplex virus type I dendritic and geographic keratitis using a corneal active storage machine
Emilie Courrier, Corantin Maurin, Victor Lambert, et al.
Acta Neuropathologica Communications
|
November 21, 2013
ALDH1 is an immunohistochemical diagnostic marker for solitary fibrous tumours and haemangiopericytomas of the meninges emerging from gene profiling study
Corinne Bouvier, François Bertucci, Philippe Métellus, et al.
Translational Lung Cancer Research
|
August 9, 2024
Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients with rare <i>KRAS</i> mutations: a real-world retrospective study
Haohua Jiang, Yujing Li, Yanan Wang, et al.
Translational Lung Cancer Research
|
January 13, 2023
Adjuvant chemotherapy for completely resected IIA-IIIA non-small cell lung cancer: compliance to guidelines, safety and efficacy in real-life practice
Anne-Laure Désage, Claire Tissot, Sophie Bayle-Bleuez, et al.
Chemotherapy
|
April 9, 2016
Clinical Impact of Bevacizumab in Patients with Relapsed Glioblastoma: Focus on a Real-Life Monocentric SurVey (SV1 Study)
Romain Rivoirard, Cyrus Chargari, Jean-Baptiste Guy, et al.
Page
of 13